Medicon Hellas S.A. (AT:MEDIC) — Market Cap & Net Worth
Market Cap & Net Worth: Medicon Hellas S.A. (MEDIC)
Medicon Hellas S.A. (AT:MEDIC) has a market capitalization of $12.15 Million (€10.40 Million) as of September 17, 2026. Listed on the AT stock exchange, this Greece-based company holds position #26644 globally and #96 in its home market, demonstrating a -3.93% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medicon Hellas S.A.'s stock price €2.69 by its total outstanding shares 4419616 (4.42 Million). Also see MEDIC total asset value for a full breakdown of the balance sheet.
Medicon Hellas S.A. Market Cap History: 2015 to 2026
Medicon Hellas S.A.'s market capitalization history from 2015 to 2026. Data shows growth from $2.31 Million to $13.90 Million (19.27% CAGR). Also see cash flow conversion of Medicon Hellas S.A. for how efficiently the company converts equity into cash flow.
Medicon Hellas S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medicon Hellas S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check MEDIC stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.88x
Medicon Hellas S.A.'s market cap is 0.88 times its annual revenue
Latest Price to Earnings (P/E) Ratio
7.25x
Medicon Hellas S.A.'s market cap is 7.25 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.31 Million | $11.46 Million | $1.67 Million | 0.20x | 1.38x |
| 2016 | $1.54 Million | $13.01 Million | $1.17 Million | 0.12x | 1.32x |
| 2017 | $4.27 Million | $12.70 Million | $1.72 Million | 0.34x | 2.49x |
| 2018 | $5.71 Million | $13.77 Million | $1.83 Million | 0.41x | 3.12x |
| 2019 | $11.81 Million | $13.45 Million | $775.17K | 0.88x | 15.24x |
| 2020 | $9.43 Million | $15.27 Million | $756.60K | 0.62x | 12.47x |
| 2021 | $24.23 Million | $21.51 Million | $3.04 Million | 1.13x | 7.97x |
| 2022 | $18.37 Million | $20.77 Million | $2.53 Million | 0.88x | 7.25x |
Competitor Companies of MEDIC by Market Capitalization
Companies near Medicon Hellas S.A. in the global market cap rankings as of September 17, 2026. Review Medicon Hellas S.A. tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Medicon Hellas S.A. by market ranking:
- Lavipharm S.A (AT:LAVI): Ranked #15097 globally with a market cap of $287.04 Million USD ( €245.52 Million EUR).
- Libet S.A. (WAR:LBT): Ranked #26635 globally with a market cap of $12.22 Million USD ( zł44.40 Million PLN).
- CAM Resources Bhd (KLSE:7128): Ranked #26645 globally with a market cap of $12.15 Million USD ( RM48.38 Million MYR).
- Binasat Communications Bhd (KLSE:0195): Ranked #26646 globally with a market cap of $12.14 Million USD ( RM48.34 Million MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15097 | Lavipharm S.A | AT:LAVI | $287.04 Million | €1.58 |
| #26635 | Libet S.A. | WAR:LBT | $12.22 Million | zł1.20 |
| #26645 | CAM Resources Bhd | KLSE:7128 | $12.15 Million | RM0.27 |
| #26646 | Binasat Communications Bhd | KLSE:0195 | $12.14 Million | RM0.08 |
Medicon Hellas S.A. Historical Marketcap From 2015 to 2026
Between 2015 and today, Medicon Hellas S.A.'s market cap moved from $2.31 Million to $ 13.90 Million, with a yearly change of 19.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €13.90 Million | +6.32% |
| 2025 | €13.07 Million | +17.13% |
| 2024 | €11.16 Million | -35.14% |
| 2023 | €17.21 Million | -6.32% |
| 2022 | €18.37 Million | -24.18% |
| 2021 | €24.23 Million | +156.84% |
| 2020 | €9.43 Million | -20.17% |
| 2019 | €11.81 Million | +106.95% |
| 2018 | €5.71 Million | +33.72% |
| 2017 | €4.27 Million | +177.47% |
| 2016 | €1.54 Million | -33.35% |
| 2015 | €2.31 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Medicon Hellas S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.15 Million USD |
| MoneyControl | $12.15 Million USD |
| MarketWatch | $12.15 Million USD |
| marketcap.company | $12.15 Million USD |
| Reuters | $12.15 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medicon Hellas S.A.
Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It al… Read more